IV Ketamine is currently the ONLY fast acting treatment proven to reduce the symptoms of even the most severe forms of depression including suicidal ideation.
Major depression affects more than 16.2 million American adults, or about 6.7% of the U.S. population age 18 and older in a given year.
Approximately 70%- 80% of women will experience, at a minimum, the “baby blues” and many more will experience the more severe condition of postpartum depression and its other subtypes.
Research has shown that a series of low-dose Ketamine infusions rapidly reduce depressive symptoms and produces results that may last as long as 2-3 months.
Clinical studies have demonstrated between 50% – 80% of patients receive clinically significant results from even ONE ketamine treatment even in treatment resistant depression (TRD).